Researchers recently investigated inebilizumab as a potential treatment option for patients with immunoglobulin G4-related disease. Test your understanding of the findings!
A recent study examines factors influencing the achievement of serum urate (SU) goals in patients with gout receiving treat-to-target urate-lowering therapy. Can you identify a key determinant of SU goal...
